5-Tetralinylamine → HCID 67186609, Verbindung

HRID 735961

Reaktionsgleichung

Reaktionsgleichung von HRID 735961
[CH2:1]([C:12]1[N:16]=[C:15]([C:17]2[CH:18]=[C:19]([CH:22]=[CH:23][CH:24]=2)[CH:20]=O)[O:14][N:13]=1)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11].[C:25]1([NH2:35])[C:34]2[CH2:33][CH2:32][CH2:31][CH2:30][C:29]=2[CH:28]=[CH:27][CH:26]=1>>[C:25]1([NH:35][CH2:20][C:19]2[CH:22]=[CH:23][CH:24]=[C:17]([C:15]3[O:14][N:13]=[C:12]([CH2:1][CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH3:11])[N:16]=3)[CH:18]=2)[C:34]2[CH2:33][CH2:32][CH2:31][CH2:30][C:29]=2[CH:28]=[CH:27][CH:26]=1

Komponenten

3

Edukt 2

HCID 166715-TetralinylamineHCID 865985383-(3-Undecyl-1,2,4-oxadiazol-5-yl)benzaldehyde

Produkt 1

HCID 67186609HCID 67186609, Verbindung

Versuchsvorschrift

The same procedure as employed in the preparation of Example 357 (step a) but using 3-(3-undecyl-1,2,4-oxadiazol-5-yl)benzaldehyde and 5,6,7,8-tetrahydronaphthalen-1-ylamine gave the title compound as an oil. M+(LC/MS(ESI)): 460.4. HPLC (Condition A), Rt: 6.32 min (HPLC purity: 68.9%).

Aufarbeitung

  1. customThe same procedure as employed in the preparation of Example 357 (step a) but

Quellen und Nachweise

ORD-Eintrag
ord-f5babc278ab74eb4b2eae1a9bb2612eb
Quelldatensatz
uspto-grants-2009_09
Patentnummer
US07592477B2

Verknüpfte Notizen

Wird geladen…